Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intratumor heterogeneity in KRAS signaling shapes treatment resistance.

iScience·2025
Same author

Editor's Note: Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo.

Cancer research·2025
Same author

Corrigendum: TAp73 is a central transcriptional regulator of airway multiciliogenesis.

Genes & development·2024
Same author

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.

eLife·2024
Same author

Oncogenic dependency plays a dominant role in the immune response to cancer.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.

bioRxiv : the preprint server for biology·2023

Related Experiment Video

Updated: May 13, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Direct reprogramming en route to neoplastic transformation

Alice Nemajerova, Oleksi Petrenko

    Cell Cycle (Georgetown, Tex.)
    |March 21, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    KrasMycreprogramming

    More Related Videos

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
    07:08

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

    Published on: February 2, 2024

    Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
    10:03

    Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

    Published on: November 11, 2016

    Related Experiment Videos

    Last Updated: May 13, 2026

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
    10:04

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

    Published on: August 1, 2025

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
    07:08

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

    Published on: February 2, 2024

    Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
    10:03

    Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

    Published on: November 11, 2016